Dare Bioscience, Inc. Class of Warrant or Right, Outstanding
Dare Bioscience, Inc. (DARE) had Class of Warrant or Right, Outstanding of 10.01 million shares as of 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2023-11-09
- 2023-09-30: Class of Warrant or Right, Outstanding 10.01M shares.
- 2023-06-30: Class of Warrant or Right, Outstanding 6.50K shares.
- 2023-03-31: Class of Warrant or Right, Outstanding 6.50K shares.
- 2022-12-31: Class of Warrant or Right, Outstanding 1.38M shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2023-09-30 | 10.01M shares 10-Q · filed 2023-11-09 |
| 2023-06-30 | 6.50K shares 10-Q · filed 2023-08-10 |
| 2023-03-31 | 6.50K shares 10-Q · filed 2023-05-11 |
| 2022-12-31 | 1.38M shares 10-K · filed 2023-03-30 |
| 2022-09-30 | 1.38M shares 10-Q · filed 2022-11-10 |
| 2022-06-30 | 1.38M shares 10-Q · filed 2022-08-09 |
| 2022-03-31 | 1.38M shares 10-Q · filed 2022-05-12 |
| 2021-12-31 | 1.38M shares 10-K · filed 2022-03-31 |
| 2021-09-30 | 1.64M shares 10-Q · filed 2021-11-10 |
| 2021-06-30 | 1.86M shares 10-Q · filed 2021-08-12 |
| 2021-03-31 | 1.86M shares 10-Q · filed 2021-05-13 |
| 2020-12-31 | 1.91M shares 10-K · filed 2021-03-30 |
| 2020-09-30 | 1.91M shares 10-Q · filed 2020-11-12 |
| 2020-06-30 | 2.03M shares 10-Q · filed 2020-08-12 |
| 2020-03-31 | 2.03M shares 10-Q · filed 2020-05-14 |
| 2019-12-31 | 3.75M shares 10-K · filed 2020-03-27 |
| 2019-09-30 | 3.75M shares 10-Q · filed 2019-11-12 |
| 2019-06-30 | 3.75M shares 10-Q · filed 2019-08-14 |
| 2019-03-31 | 3.75M shares 10-Q · filed 2019-05-14 |
| 2018-12-31 | 3.75M shares 10-K · filed 2019-04-01 |
| 2018-09-30 | 3.75M shares 10-Q · filed 2018-11-13 |
| 2018-06-30 | 3.75M shares 10-Q · filed 2018-08-13 |
| 2018-03-31 | 3.75M shares 10-Q · filed 2018-05-14 |
| 2017-12-31 | 30.50K shares 10-K · filed 2018-03-28 |
| 2017-09-30 | 30.50K shares 10-Q · filed 2017-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |